z-logo
open-access-imgOpen Access
Pituitary Adenylate Cyclase Activating Polypeptide Elicits Neuroprotection Against Acute Ischemic Neuronal Cell Death Associated with NMDA Receptors
Author(s) -
Yuji Kaneko,
Julian P. Tuazon,
Xunming Ji,
Cesar V. Borlongan
Publication year - 2018
Publication title -
cellular physiology and biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.486
H-Index - 87
eISSN - 1421-9778
pISSN - 1015-8987
DOI - 10.1159/000495722
Subject(s) - neuroprotection , pituitary adenylate cyclase activating peptide , adenylate kinase , receptor , nmda receptor , neuroscience , programmed cell death , medicine , pharmacology , cyclase , endocrinology , chemistry , biology , neuropeptide , vasoactive intestinal peptide , biochemistry , apoptosis
The endogenous neurotrophic peptides pituitary adenylate cyclase-activating polypeptides (PACAP-27/38) protect against stroke, but the molecular mechanism remains unknown.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom